China National Pharmaceutical Group Corporation (600420.SH): Sodium bicarbonate injection increases specifications and passes generic drug consistency evaluation.

The IntelligenceFinance APP reports that China National Pharmaceutical Group Corporation (600420.SH) has announced that its wholly-owned subsidiary, China National Pharmaceutical Group Rongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as China National Pharmaceutical Rongsheng), recently received the Approval Notice for Drug Supplementary Application issued by the National Medical Products Administration. This approval allows for an increase in the specification of sodium bicarbonate injection and passes the generic drug quality and efficacy consistency evaluation (hereinafter referred to as consistency evaluation), and issues the drug approval number.